FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023580063> ?p ?o ?g. }

• W2023580063 endingPage "1250" @default.
• W2023580063 startingPage "1244" @default.
• W2023580063 abstract "Background: Galectin-3 (G3) immunostaining of fine-needle aspiration (FNA) samples from thyroid nodules is very useful for the diagnosis of malignancy. The objective of the present study was to determine whether the absence of G3 immunostaining in preoperative FNA samples is associated with favorable clinicopathological parameters, including lymph node (LN) metastasis, in papillary thyroid carcinoma (PTC). Methods: The records of 868 patients with PTC who had prethyroidectomy ultrasonography-guided FNA with G3 immunostaining between January 2006 and December 2009 were retrospectively reviewed. G3 immunostaining was considered positive if the percentage of tumor cells showing definite cytoplasmic immunostaining exceeded 5%. Patients who had negative G3 immunostaining of FNA samples were assigned to the G3-negative (G3N) group; whereas those who had positive G3 immunostaining were assigned to the G3-positive (G3P) group. Results: There were 92 patients who were assigned to the G3N group (10.6%) because of the negative staining for G3 in the preoperative FNA samples from their thyroid nodules. The proportion of PTC subtypes in the G3N and G3P groups was similar (p=0.376). There was less frequent thyroid capsular invasion (46.7% vs. 66.5%, p<0.001), extrathyroidal extension (28.3% vs. 48.5%, p<0.001), and LN metastasis (22.2% vs. 48.7%, p<0.001) in the G3N group than the G3P group. In multivariate regression analysis, G3N expression predicted a lower risk of LN metastasis (odds ratio=0.37, 95% confidence interval 0.18–0.78) after adjustment for other clinicopathological parameters. Over a median follow-up of 33 months, no association was observed between G3N and disease-free survival. Conclusion: The absence of G3 expression in FNA samples from PTC is associated with pathological parameters considered less aggressive than is the case for PTCs with G3 expression, including being a negative predictor of negative LN involvement. Long-term follow-up studies, however, are needed to verify whether G3N patients have lower recurrence and mortality rates." @default.
• W2023580063 created "2016-06-24" @default.
• W2023580063 creator A5017460777 @default.
• W2023580063 creator A5019582170 @default.
• W2023580063 creator A5022134280 @default.
• W2023580063 creator A5022724648 @default.
• W2023580063 creator A5024366237 @default.
• W2023580063 creator A5025987939 @default.
• W2023580063 creator A5027561236 @default.
• W2023580063 creator A5040409719 @default.
• W2023580063 creator A5042388176 @default.
• W2023580063 creator A5044282066 @default.
• W2023580063 creator A5066669488 @default.
• W2023580063 creator A5070510848 @default.
• W2023580063 creator A5075923982 @default.
• W2023580063 date "2012-12-01" @default.
• W2023580063 modified "2023-09-26" @default.
• W2023580063 title "Absence of Galectin-3 Immunostaining in Fine-Needle Aspiration Cytology Specimens from Papillary Thyroid Carcinoma Is Associated with Favorable Pathological Indices" @default.
• W2023580063 cites W1548723165 @default.
• W2023580063 cites W1965275368 @default.
• W2023580063 cites W1965481481 @default.
• W2023580063 cites W1968460133 @default.
• W2023580063 cites W1971899594 @default.
• W2023580063 cites W1975306842 @default.
• W2023580063 cites W1979901510 @default.
• W2023580063 cites W1989944041 @default.
• W2023580063 cites W1990196512 @default.
• W2023580063 cites W1998629131 @default.
• W2023580063 cites W2006051699 @default.
• W2023580063 cites W2006052075 @default.
• W2023580063 cites W2016235652 @default.
• W2023580063 cites W2033882181 @default.
• W2023580063 cites W2069212900 @default.
• W2023580063 cites W2069392223 @default.
• W2023580063 cites W2080995367 @default.
• W2023580063 cites W2084929142 @default.
• W2023580063 cites W2088349931 @default.
• W2023580063 cites W2092319839 @default.
• W2023580063 cites W2092846304 @default.
• W2023580063 cites W2099594989 @default.
• W2023580063 cites W2109483629 @default.
• W2023580063 cites W2115142032 @default.
• W2023580063 cites W2117817789 @default.
• W2023580063 cites W2140473930 @default.
• W2023580063 cites W2155854398 @default.
• W2023580063 cites W2157172418 @default.
• W2023580063 cites W4232244566 @default.
• W2023580063 doi "https://doi.org/10.1089/thy.2011.0166" @default.
• W2023580063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22892040" @default.
• W2023580063 hasPublicationYear "2012" @default.
• W2023580063 type Work @default.
• W2023580063 sameAs 2023580063 @default.
• W2023580063 citedByCount "12" @default.
• W2023580063 countsByYear W20235800632013 @default.
• W2023580063 countsByYear W20235800632014 @default.
• W2023580063 countsByYear W20235800632015 @default.
• W2023580063 countsByYear W20235800632017 @default.
• W2023580063 countsByYear W20235800632018 @default.
• W2023580063 countsByYear W20235800632020 @default.
• W2023580063 crossrefType "journal-article" @default.
• W2023580063 hasAuthorship W2023580063A5017460777 @default.
• W2023580063 hasAuthorship W2023580063A5019582170 @default.
• W2023580063 hasAuthorship W2023580063A5022134280 @default.
• W2023580063 hasAuthorship W2023580063A5022724648 @default.
• W2023580063 hasAuthorship W2023580063A5024366237 @default.
• W2023580063 hasAuthorship W2023580063A5025987939 @default.
• W2023580063 hasAuthorship W2023580063A5027561236 @default.
• W2023580063 hasAuthorship W2023580063A5040409719 @default.
• W2023580063 hasAuthorship W2023580063A5042388176 @default.
• W2023580063 hasAuthorship W2023580063A5044282066 @default.
• W2023580063 hasAuthorship W2023580063A5066669488 @default.
• W2023580063 hasAuthorship W2023580063A5070510848 @default.
• W2023580063 hasAuthorship W2023580063A5075923982 @default.
• W2023580063 hasConcept C121608353 @default.
• W2023580063 hasConcept C126322002 @default.
• W2023580063 hasConcept C142724271 @default.
• W2023580063 hasConcept C156957248 @default.
• W2023580063 hasConcept C204232928 @default.
• W2023580063 hasConcept C207886595 @default.
• W2023580063 hasConcept C2775934546 @default.
• W2023580063 hasConcept C2776170712 @default.
• W2023580063 hasConcept C2777546739 @default.
• W2023580063 hasConcept C2779013556 @default.
• W2023580063 hasConcept C2779022025 @default.
• W2023580063 hasConcept C2779399171 @default.
• W2023580063 hasConcept C2993294228 @default.
• W2023580063 hasConcept C4224716 @default.
• W2023580063 hasConcept C526584372 @default.
• W2023580063 hasConcept C71924100 @default.
• W2023580063 hasConcept C90924648 @default.
• W2023580063 hasConceptScore W2023580063C121608353 @default.
• W2023580063 hasConceptScore W2023580063C126322002 @default.
• W2023580063 hasConceptScore W2023580063C142724271 @default.
• W2023580063 hasConceptScore W2023580063C156957248 @default.
• W2023580063 hasConceptScore W2023580063C204232928 @default.
• W2023580063 hasConceptScore W2023580063C207886595 @default.
• W2023580063 hasConceptScore W2023580063C2775934546 @default.
• W2023580063 hasConceptScore W2023580063C2776170712 @default.

• next